The Effects of the Water-exchanged Colonoscopy on Adenoma Detection Rate
1 other identifier
interventional
3,303
1 country
6
Brief Summary
Water exchange method has been shown to reduce medication requirement and pain experienced during colonoscopy. It may increase the adenoma detection rate (ADR). Water exchange provides salvage cleansing and the refractive index of water (n equals about 1.3) is larger than that of air, which creates optical distortion that likely contributes to objects appearing larger underwater, making smaller lesions easier to visualize and it may help draw attention to those smaller lesions during withdraw. These principles facilitate to the higher adenoma detection rate. There is a large number of literature on the adenoma detection rate during water exchange colonoscopy, but most studies have been conducted in only one centre, simple-size, and under sedation patients, the influence of adenoma detection rate under unsedation patients was unclear. The aim of this study is to compare the ADR of colonoscopy by using the water exchange method versus the conventional air method in unsedation patients in multiple centers in China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2014
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 8, 2014
CompletedFirst Posted
Study publicly available on registry
May 12, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedNovember 10, 2015
August 1, 2015
1.2 years
May 8, 2014
November 8, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adenoma detection rate
The proportion of participants with at least one adenoma in each group
up to one year
Secondary Outcomes (4)
Pain Scores on the Visual Analog Scale
up to one year
Cecal intubation success rate
up to one year
Cecum intubation time
up to one year
Quality of Bowel Preparation
up to one year
Study Arms (2)
Air colonoscopy
NO INTERVENTIONColonoscopy will be performed without medications and with judicious air insufflation during colonoscope insertion.
Water colonoscopy
OTHERColonoscopy will be performed without medications and aided by water infusion in-lieu of air insufflation during insertion of the colonoscope.
Interventions
Colonoscopy will be performed without medications and aided by water infusion in-lieu of air insufflation during insertion of the colonoscope. The water infusion involves putting warm sterile water into the colon to open up the colon for advancement of the colonoscope until the end of the colon (cecum) is reached. The water is delivered through scope irrigation channel by an infusion pump equipped with a foot switch which will be controlled by the endoscopist. Infused water used to cleanse residual fecal matter will be suctioned as needed to clear the colonic lumen.
Eligibility Criteria
You may qualify if:
- age 18-80 patients with intact colon and rectum
You may not qualify if:
- prior finding of severe colorectal stricture;
- solid fetus contained in the last stool before colonoscopy
- no bowel preparation or cleansed by enema/lavage
- without the requirement of reaching cecum
- known colorectal polyps or polyposis syndrome without complete removal previously
- pregnant women
- hemodynamically unstable
- patients who cannot give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Chaoyang Hospital
Beijing, Beijing Municipality, 100020, China
General Hospital of Guangzhou Military Command
Guangzhou, Guangdong, 510010, China
Union Hospital of Tongji Medical college
Wuhan, Hubei, 430022, China
Xijing Hospital of Digestive Diseases
Xi'an, Shaanxi, 710032, China
Renji Hospital
Shanghai, Shanghai Municipality, 200000, China
First Teaching Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, 830054, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yanglin Pan, M.D.
Air Force Military Medical University, China
- PRINCIPAL INVESTIGATOR
Felix W. Leung, M.D.
Sepulveda Ambulatory Care Center, VAGLAHS
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associated professor
Study Record Dates
First Submitted
May 8, 2014
First Posted
May 12, 2014
Study Start
April 1, 2014
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
November 10, 2015
Record last verified: 2015-08